{"database": "openregs", "table": "documents", "rows": [["FDA-2019-N-2650-0001", "FDA", "FDA-2019-N-2650", "Investigational New Drug Applications; Exemptions for Clinical Investigations\nTo Evaluate a Drug Use of a Product Lawfully Marketed as a Conventional\nFood, Dietary Supplement, or Cosmetic", "Proposed Rule", "Amendment", "2022-12-09T05:00:00Z", 2022, 12, "2022-12-09T05:00:00Z", "2023-03-10T04:59:59Z", "2023-03-11T02:00:26Z", "2022-26728", 0, 0, "090000648552a62c"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2019-N-2650-0001"], "units": {}, "query_ms": 52.212173817679286, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}